April 11, 2024 Uncategorized BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference Read More
April 3, 2024 Uncategorized BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non- hallucinogenic LSD-based Drug Candidate BETR-001 Read More
